Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × Ifosfamide × Clear all

Phase

Phase 2 4 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Lymphoma, Large B-Cell, Diffuse 6 Osteosarcoma 4 Lymphoma 4 Wilms Tumor 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Neoplasms 3 Carcinoma, Renal Cell 3 Retinoblastoma 2 Optic Nerve Glioma 2 Neuroblastoma 2 Melanoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Carcinoma, Hepatocellular 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocytopenia 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1

Interventions

Cyclophosphamide 33 fludarabine 26 Rituximab 23 obinutuzumab 9 fludarabine phosphate 9 Bendamustine Hydrochloride 9 pembrolizumab 7 Vincristine 6 Specimen Handling 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 Etoposide 6 venetoclax 5 ibrutinib 5 Inotuzumab Ozogamicin 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 Interleukin-2 4 polatuzumab vedotin 3 glofitamab 3 Radiation 3 Nivolumab 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01300793 2012-09-26

V-RICE

University of California, San Francisco

Phase 1 Terminated

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡